Llwytho...
Cholesterol-lowering drugs: science and marketing
Long-term use of statin therapy is essential to obtain clinical benefits, but adherence is often suboptimal and some patients are also reported to fail because of ‘statin resistance'. The identification of PCSK9 as a key factor in the LDL clearance pathway has led to the development of new mono...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J R Soc Med |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
SAGE Publications
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5305008/ https://ncbi.nlm.nih.gov/pubmed/28084157 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0141076816681951 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|